| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18739658
[patent_doc_number] => 20230348620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/999769
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999769 | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF | May 27, 2021 | Pending |
Array
(
[id] => 20742965
[patent_doc_number] => 12642847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Human monoclonal antibodies to Venezuelan equine encephalitis virus and uses therefor
[patent_app_type] => utility
[patent_app_number] => 17/999366
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26249
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999366 | Human monoclonal antibodies to Venezuelan equine encephalitis virus and uses therefor | May 26, 2021 | Issued |
Array
(
[id] => 18413178
[patent_doc_number] => 11667711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC)
[patent_app_type] => utility
[patent_app_number] => 17/331344
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10907
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331344 | Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC) | May 25, 2021 | Issued |
Array
(
[id] => 18467055
[patent_doc_number] => 20230201335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/927477
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927477 | Antigen Presenting Polypeptide Complexes and Methods of Use Thereof | May 25, 2021 | Pending |
Array
(
[id] => 18496189
[patent_doc_number] => 20230218744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR
[patent_app_type] => utility
[patent_app_number] => 18/000380
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000380 | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR | May 25, 2021 | Pending |
Array
(
[id] => 17784728
[patent_doc_number] => 11407840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer
[patent_app_type] => utility
[patent_app_number] => 17/328597
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 54839
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328597 | Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer | May 23, 2021 | Issued |
Array
(
[id] => 17080649
[patent_doc_number] => 20210275655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/327193
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327193 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS | May 20, 2021 | Abandoned |
Array
(
[id] => 19043594
[patent_doc_number] => 11932678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
[patent_app_type] => utility
[patent_app_number] => 17/314650
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 52133
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314650 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | May 6, 2021 | Issued |
Array
(
[id] => 17082082
[patent_doc_number] => 20210277088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/314688
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314688 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | May 6, 2021 | Issued |
Array
(
[id] => 17082081
[patent_doc_number] => 20210277087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/314668
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314668 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | May 6, 2021 | Issued |
Array
(
[id] => 20701392
[patent_doc_number] => 12624092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Compositions and methods for membrane protein structure determination
[patent_app_type] => utility
[patent_app_number] => 17/997720
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 6452
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997720 | Compositions and methods for membrane protein structure determination | May 5, 2021 | Issued |
Array
(
[id] => 19608905
[patent_doc_number] => 12157771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Proteins binding NKG2D, CD16 and CLEC12A
[patent_app_type] => utility
[patent_app_number] => 17/308691
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 483
[patent_figures_cnt] => 1064
[patent_no_of_words] => 111584
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308691 | Proteins binding NKG2D, CD16 and CLEC12A | May 4, 2021 | Issued |
Array
(
[id] => 20548795
[patent_doc_number] => 12559575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Isoform-independent antibodies to lipoprotein(a)
[patent_app_type] => utility
[patent_app_number] => 17/921621
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 17200
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/921621 | Isoform-independent antibodies to lipoprotein(a) | Apr 26, 2021 | Issued |
Array
(
[id] => 18738014
[patent_doc_number] => 20230346919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/918792
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918792 | SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS | Apr 13, 2021 | Pending |
Array
(
[id] => 17007082
[patent_doc_number] => 20210238243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/229592
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229592 | Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods | Apr 12, 2021 | Issued |
Array
(
[id] => 17170378
[patent_doc_number] => 20210324048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/226153
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226153 | Compounds specific to coronavirus S protein and uses thereof | Apr 8, 2021 | Issued |
Array
(
[id] => 20957744
[patent_doc_number] => 12728159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-08
[patent_title] => Coronavirus vaccines compositions and method of using same
[patent_app_type] => utility
[patent_app_number] => 17/914293
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 8
[patent_no_of_words] => 8596
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914293 | CORONAVIRUS VACCINES COMPOSITIONS AND METHOD OF USING SAME | Mar 22, 2021 | Pending |
Array
(
[id] => 18366066
[patent_doc_number] => 20230147657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/912726
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912726 | CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HUMAN CD45RC AND USES THEREOF | Mar 18, 2021 | Pending |
Array
(
[id] => 16946738
[patent_doc_number] => 20210205429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/205634
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205634 | Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor | Mar 17, 2021 | Abandoned |
Array
(
[id] => 18312687
[patent_doc_number] => 20230116587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/911326
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911326 | MONOCLONAL ANTIBODY AGAINST NOVEL CORONAVIRUS AND APPLICATION THEREOF | Mar 11, 2021 | Pending |